[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fF6tmCRjp6zuM1VR99na_Kteid4QtvNZbjVm4BYZSGb0":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":12,"question":16,"related":17,"source":28,"type":29},[],"2026-05-06 12:22:34",359149989,[8,9,10,11],"血液循环","肿瘤渗透","肿瘤抑制","细胞摄取",{"courseId":13,"courseImg":14,"courseName":15},"53e1d2ef4961cca8eea3e23969ad2cb9","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","默认课程","纳米药物载体向实体瘤传输过程的关键级联步骤不包括( )",[18,30,39,48,57,66,75,84,87,96],{"answer":19,"createTime":20,"id":21,"options":22,"question":27,"source":28,"type":29},[],"2026-05-13 16:29:09",359149982,[23,24,25,26],"会使药物分子失去生物活性","粒径过大","制备复杂","具有主动靶向性","一代普通脂质体的主要缺点是( )","v1",0,{"answer":31,"createTime":20,"id":32,"options":33,"question":38,"source":28,"type":29},[],359149983,[34,35,36,37],"晶粒易长大或团聚","超导相向正常相的转变","纳米材料密度增大","金属纳米相材料电阻增大与临界尺寸现象","下列关于纳米材料小尺寸效应主要影响的描述,错误的是( )",{"answer":40,"createTime":20,"id":41,"options":42,"question":47,"source":28,"type":29},[],359149984,[43,44,45,46],"物理包埋法","高温烧结法","化学键合法","静电作用法","下列不属于纳米药物载体制备方法的是( )",{"answer":49,"createTime":20,"id":50,"options":51,"question":56,"source":28,"type":29},[],359149985,[52,53,54,55],"多层同心的多层脂质体(MLV)","大单层脂质体(LUV)","非同心多囊泡脂质体(MVL)","小单层脂质体(SUV)","脂质体按不同直径大小以及内囊数目可分为多种类型,直径小于 100nm 的是( )",{"answer":58,"createTime":20,"id":59,"options":60,"question":65,"source":28,"type":29},[],359149986,[61,62,63,64],"力","声","化学稳定性","光","小尺寸效应中,当超细微粒的尺寸与光波波长等物理尺寸相当或更小时,晶体周期性的边界条件被破坏,不会导致( )特性呈现新的效应",{"answer":67,"createTime":20,"id":68,"options":69,"question":74,"source":28,"type":29},[],359149987,[70,71,72,73],"聚磷腈","聚碳酸酯","壳聚糖","聚酯类","下列属于天然高分子载体材料的是( )",{"answer":76,"createTime":20,"id":77,"options":78,"question":83,"source":28,"type":29},[],359149988,[79,80,81,82],"半衰期和组织分布","溶解度","颜色和气味","酸碱度","构建纳米药物载体的主要目标之一是调控药物在体内的( )",{"answer":85,"createTime":5,"id":6,"options":86,"question":16,"source":28,"type":29},[],[8,9,10,11],{"answer":88,"createTime":20,"id":89,"options":90,"question":95,"source":28,"type":29},[],359149990,[91,92,93,94],"粒径 130 nm 的紫杉醇 - 白蛋白结合型纳米颗粒","粒径 130 nm 的雷帕霉素 - 白蛋白结合型纳米颗粒","粒径 130 nm 的 17AAG - 白蛋白结合型纳米颗粒","粒径 130 nm 的多西紫杉醇 - 白蛋白结合型纳米颗粒","以 "凯素" 为代表的白蛋白结合技术制备的纳米药物是( )",{"answer":97,"createTime":20,"id":98,"options":99,"question":104,"source":28,"type":29},[],359149991,[100,101,102,103],"聚乙二醇 - 聚酯","聚乳酸羟基乙酸","阳离子聚合物","聚左旋赖氨酸","纳米药物载体中聚合物胶束比较常见,其中应用最为广泛的是( )"]